Glen Santangelo
Stock Analyst at Jefferies
(2.57)
# 2,278
Out of 4,960 analysts
76
Total ratings
48.94%
Success rate
2.71%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.68 | +4.17% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $91.01 | -12.10% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.65 | +22.07% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $36.24 | +40.73% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $7.75 | -22.58% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $21.72 | +1.29% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $14.66 | +36.43% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $25.84 | -30.34% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $23.53 | +2.00% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $44.57 | -48.40% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $18.46 | +24.59% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $39.11 | +12.50% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $17.91 | -5.08% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $156.62 | +46.85% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $5.47 | +1,729.83% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $30.50 | +129.51% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $22.67 | +142.61% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $11.91 | +34.34% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $4.85 | +188.66% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $67.74 | -32.09% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $89.82 | -10.93% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.28 | +753.66% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $29.75 | +135.29% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.15 | +1,578.32% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.80 | -28.57% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.56 | +930.70% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.06 | +786.70% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $71.30 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $689.45 | -75.49% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $148.10 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $69.60 | +17.82% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $149.57 | +67.15% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $12.07 | +546.23% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.68
Upside: +4.17%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $91.01
Upside: -12.10%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.65
Upside: +22.07%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $36.24
Upside: +40.73%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $7.75
Upside: -22.58%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $21.72
Upside: +1.29%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $14.66
Upside: +36.43%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $25.84
Upside: -30.34%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $23.53
Upside: +2.00%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $44.57
Upside: -48.40%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $18.46
Upside: +24.59%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $39.11
Upside: +12.50%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $17.91
Upside: -5.08%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $156.62
Upside: +46.85%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $5.47
Upside: +1,729.83%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $30.50
Upside: +129.51%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $22.67
Upside: +142.61%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $11.91
Upside: +34.34%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.85
Upside: +188.66%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $67.74
Upside: -32.09%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $89.82
Upside: -10.93%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.28
Upside: +753.66%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $29.75
Upside: +135.29%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.15
Upside: +1,578.32%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.80
Upside: -28.57%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.56
Upside: +930.70%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.06
Upside: +786.70%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $71.30
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $689.45
Upside: -75.49%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $148.10
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $69.60
Upside: +17.82%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $149.57
Upside: +67.15%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $12.07
Upside: +546.23%